A citation-based method for searching scientific literature

Ryan S Nelson, Nathan D Seligson, Sal Bottiglieri, Estrella Carballido, Alex Del Cueto, Iman Imanirad, Richard Levine, Alexander S Parker, Sandra M Swain, Emma M Tillman, J Kevin Hicks. Cancers (Basel) 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Dawn L Hershman, Theresa Shao, Lawrence H Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn Kwan, Scarlett Lin Gomez, Alfred I Neugut. Breast Cancer Res Treat 2011
487
33

Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing.
Katarzyna Drozda, Michael A Pacanowski. Pharmacotherapy 2017
7
33

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, Meera Prasad, Michael Walsh, Ahmet Zehir, Ai Ni, Tinu Thomas, Ryma Benayed, Asad Ashraf,[...]. JAMA Oncol 2016
170
33

Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.
Alexandre Vivot, Isabelle Boutron, Philippe Ravaud, Raphaël Porcher. Genet Med 2015
25
33

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
Paul A Harris, Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G Conde. J Biomed Inform 2009
33

The Sequence Alignment/Map format and SAMtools.
Heng Li, Bob Handsaker, Alec Wysoker, Tim Fennell, Jue Ruan, Nils Homer, Gabor Marth, Goncalo Abecasis, Richard Durbin. Bioinformatics 2009
33

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.
Mary V Relling, Matthias Schwab, Michelle Whirl-Carrillo, Guilherme Suarez-Kurtz, Ching-Hon Pui, Charles M Stein, Ann M Moyer, William E Evans, Teri E Klein, Federico Guillermo Antillon-Klussmann,[...]. Clin Pharmacol Ther 2019
176
33

ClinVar: improving access to variant interpretations and supporting evidence.
Melissa J Landrum, Jennifer M Lee, Mark Benson, Garth R Brown, Chen Chao, Shanmuga Chitipiralla, Baoshan Gu, Jennifer Hart, Douglas Hoffman, Wonhee Jang,[...]. Nucleic Acids Res 2018
955
33

Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines.
Lucía Cortejoso, Xandra García-González, María I García, Pilar García-Alfonso, María Sanjurjo, Luis A López-Fernández. Pharmacogenomics 2016
19
33


The Ensembl Variant Effect Predictor.
William McLaren, Laurent Gil, Sarah E Hunt, Harpreet Singh Riat, Graham R S Ritchie, Anja Thormann, Paul Flicek, Fiona Cunningham. Genome Biol 2016
33

Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience.
Con Murphy, Stephen Byrne, Gul Ahmed, Andrew Kenny, James Gallagher, Harry Harvey, Eoin O'Farrell, Brian Bird. Dose Response 2018
13
33

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Ursula Amstutz, Linda M Henricks, Steven M Offer, Julia Barbarino, Jan H M Schellens, Jesse J Swen, Teri E Klein, Howard L McLeod, Kelly E Caudle, Robert B Diasio,[...]. Clin Pharmacol Ther 2018
183
33




Cost-effectiveness analysis of UGT1A1*6/*28 genotyping for preventing FOLFIRI-induced severe neutropenia in Chinese colorectal cancer patients.
XiaoXia Wei, JiaQin Cai, Hong Sun, Na Li, Chenxia Xu, Guifeng Zhang, Yuxia Sui, Jie Zhuang, Bin Zheng. Pharmacogenomics 2019
6
33

The mutational constraint spectrum quantified from variation in 141,456 humans.
Konrad J Karczewski, Laurent C Francioli, Grace Tiao, Beryl B Cummings, Jessica Alföldi, Qingbo Wang, Ryan L Collins, Kristen M Laricchia, Andrea Ganna, Daniel P Birnbaum,[...]. Nature 2020
33

Pharmacogenomic potential in advanced cancer patients.
Dan Nichols, Susanne Arnold, Heidi L Weiss, Jianrong Wu, Eric B Durbin, Rachel Miller, Jill Kolesar. Am J Health Syst Pharm 2019
3
33

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.
R S Gammal, M H Court, C E Haidar, O F Iwuchukwu, A H Gaur, M Alvarellos, C Guillemette, J L Lennox, M Whirl-Carrillo, S S Brummel,[...]. Clin Pharmacol Ther 2016
87
33

The REDCap consortium: Building an international community of software platform partners.
Paul A Harris, Robert Taylor, Brenda L Minor, Veida Elliott, Michelle Fernandez, Lindsay O'Neal, Laura McLeod, Giovanni Delacqua, Francesco Delacqua, Jacqueline Kirby,[...]. J Biomed Inform 2019
33

Precision medicine: Opportunities for health-system pharmacists.
Jill M Kolesar, Lee C Vermeulen. Am J Health Syst Pharm 2021
1
100

Effectiveness and safety of reduced-dose fluoropyrimidine therapy in patients carrying the DPYD*2A variant: A matched pair analysis.
Linda M Henricks, Lisanne N van Merendonk, Didier Meulendijks, Maarten J Deenen, Jos H Beijnen, Anthonius de Boer, Annemieke Cats, Jan H M Schellens. Int J Cancer 2019
11
33

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
Daniel C Koboldt, Qunyuan Zhang, David E Larson, Dong Shen, Michael D McLellan, Ling Lin, Christopher A Miller, Elaine R Mardis, Li Ding, Richard K Wilson. Genome Res 2012
33

The ExAC browser: displaying reference data information from over 60 000 exomes.
Konrad J Karczewski, Ben Weisburd, Brett Thomas, Matthew Solomonson, Douglas M Ruderfer, David Kavanagh, Tymor Hamamsy, Monkol Lek, Kaitlin E Samocha, Beryl B Cummings,[...]. Nucleic Acids Res 2017
286
33

Personalized genomic analyses for cancer mutation discovery and interpretation.
Siân Jones, Valsamo Anagnostou, Karli Lytle, Sonya Parpart-Li, Monica Nesselbush, David R Riley, Manish Shukla, Bryan Chesnick, Maura Kadan, Eniko Papp,[...]. Sci Transl Med 2015
244
33

The International Genome Sample Resource (IGSR) collection of open human genomic variation resources.
Susan Fairley, Ernesto Lowy-Gallego, Emily Perry, Paul Flicek. Nucleic Acids Res 2020
32
33


A cost effectiveness analysis of thiopurine methyltransferase testing for guiding 6-mercaptopurine dosing in children with acute lymphoblastic leukemia.
Jennifer R Donnan, Wendy J Ungar, Maria Mathews, Rebecca L Hancock-Howard, Proton Rahman. Pediatr Blood Cancer 2011
28
33



The cost-effectiveness of a pharmacogenetic test: a trial-based evaluation of TPMT genotyping for azathioprine.
Alexander J Thompson, William G Newman, Rachel A Elliott, Stephen A Roberts, Karen Tricker, Katherine Payne. Value Health 2014
49
33

The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance.
Bettina Butzke, Fuat S Oduncu, Franziska Severin, Arne Pfeufer, Volker Heinemann, Clemens Giessen-Jung, Björn Stollenwerk, Wolf H Rogowski. Acta Oncol 2016
17
33

Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer.
Ji Zhu, Anwen Liu, Xinchen Sun, Luying Liu, Yaqun Zhu, Tao Zhang, Jianhui Jia, Shisheng Tan, Junxin Wu, Xin Wang,[...]. J Clin Oncol 2020
10
33

Patient Enrichment for Precision-Based Cancer Clinical Trials: Using Prospective Cohort Surveillance as an Approach to Improve Clinical Trials.
William S Dalton, Daniel Sullivan, Jeffrey Ecsedy, Michael A Caligiuri. Clin Pharmacol Ther 2018
10
33

Implementing personalized medicine in a cancer center.
David A Fenstermacher, Robert M Wenham, Dana E Rollison, William S Dalton. Cancer J 2011
92
33

Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program.
Daniel L Hertz, Andrew Glatz, Amy L Pasternak, Robert J Lonigro, Pankaj Vats, Yi-Mi Wu, Bailey Anderson, Erica Rabban, Erika Mora, Kevin Frank,[...]. JCO Precis Oncol 2018
6
33

Cost-effectiveness of UGT1A1*28 genotyping in preventing severe neutropenia following FOLFIRI therapy in colorectal cancer.
Solen Pichereau, Anne Le Louarn, Thierry Lecomte, Hélène Blasco, Chantal Le Guellec, Hélène Bourgoin. J Pharm Pharm Sci 2010
25
33

Brentuximab vedotin: axonal microtubule's Apollyon.
S Mariotto, S Ferrari, M Sorio, F Benedetti, G Tridente, T Cavallaro, A Gajofatto, S Monaco. Blood Cancer J 2015
14
33

UGT1A1 polymorphisms in cancer: impact on irinotecan treatment.
Masashi Takano, Toru Sugiyama. Pharmgenomics Pers Med 2017
31
33

Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer.
Andrew K L Goey, Tristan M Sissung, Cody J Peer, Jane B Trepel, Min-Jung Lee, Yusuke Tomita, Sheryl Ehrlich, Christine Bryla, Sanjeeve Balasubramaniam, Richard Piekarz,[...]. J Clin Pharmacol 2016
22
33


Cytoplasmic cyclin D1 regulates glioblastoma dissemination.
Tània Cemeli, Marta Guasch-Vallés, Mireia Nàger, Isidre Felip, Serafí Cambray, Maria Santacana, Sònia Gatius, Neus Pedraza, Xavier Dolcet, Francisco Ferrezuelo,[...]. J Pathol 2019
9
33

JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.
Tianyi Wang, Johannes Francois Fahrmann, Heehyoung Lee, Yi-Jia Li, Satyendra C Tripathi, Chanyu Yue, Chunyan Zhang, Veronica Lifshitz, Jieun Song, Yuan Yuan,[...]. Cell Metab 2018
225
33

IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway.
Qianqian Zheng, Shuo Diao, Qi Wang, Chen Zhu, Xun Sun, Bo Yin, Xinwen Zhang, Xin Meng, Biao Wang. J Cell Mol Med 2019
12
33

Culture on 3D Chitosan-Hyaluronic Acid Scaffolds Enhances Stem Cell Marker Expression and Drug Resistance in Human Glioblastoma Cancer Stem Cells.
Kui Wang, Forrest M Kievit, Ariane E Erickson, John R Silber, Richard G Ellenbogen, Miqin Zhang. Adv Healthc Mater 2016
31
33

Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2.
Guo-Zhong Yi, Guanglong Huang, Manlan Guo, Xi'an Zhang, Hai Wang, Shengze Deng, Yaomin Li, Wei Xiang, Ziyang Chen, Jun Pan,[...]. Brain 2019
47
33


The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Jiawen Qian, Chen Wang, Bo Wang, Jiao Yang, Yuedi Wang, Feifei Luo, Junying Xu, Chujun Zhao, Ronghua Liu, Yiwei Chu. J Neuroinflammation 2018
71
33

Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.
Tadej Strojnik, Gro Vatne Røsland, Per Oystein Sakariassen, Rajko Kavalar, Tamara Lah. Surg Neurol 2007
162
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.